Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EJ6795 / 1||LA / OT|
Administered by: Other Purchased by: ??
Symptoms: Pulmonary embolism
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Medical History/Concurrent Conditions: Immobile; Vascular disorder (It is stated in the report that the patient had known vascular disease,
Diagnostic Lab Data:
CDC 'Split Type': NOPFIZER INC2021561373
Write-up: EMBOLISM PULMONARY; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB [NO-NOMAADVRE-FHI-2021-Urjr93], Safety Report Unique Identifier [NO-NOMAADVRE-E2B_00028837]. A 71-years-old female patient received first dose of BNT162b2 (COMIRNATY, Solution for injection, Lot number: EJ6795) intramuscular on 07Jan2021 12:48 in the arm left at single dose for COVID-19 immunization. Concomitant drugs were not reported. On 24Jan2021, the patient developed pulmonary embolism. The outcome of the event was fatal, the patient died on 12Feb2021. It is stated in the report that it is uncertain whether the vaccine was the cause of the pulmonary embolism. The patient was immobile, had known vascular disease. Also there was a period of 17 days between the vaccination and the pulmonary embolism. The Regional Pharmacist assessed the causal relationship between bnt162b2 (COMIRNATY) and the reported event as Possible. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Pulmonary embolism
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166